Skip to main content
OpenTrials

Clinical trial condition

Squamous Cell Carcinoma of Head and Neck

Explore clinical trials studying Squamous Cell Carcinoma of Head and Neck. Study availability and eligibility vary by location and protocol.

1,365 public trials 360 recruiting studies
Refine in advanced search Browse all conditions

Squamous Cell Carcinoma of Head and Neck trial results

Active, Not Recruiting

Testing the Addition of an Anti-cancer Drug, BAY 1895344, With Radiation Therapy to the Usual Pembrolizumab Treatment for Recurrent Head and Neck Cancer

NCT04576091

Conditions
Carcinoma, Carcinoma, Squamous Cell, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, +52 more
Locations
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Northwestern University Chicago, Illinois, United States
  • University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
View Trial Details
Active, Not Recruiting

Phase II Trial of Pembrolizumab in Recurrent or Metastatic HNSCC

NCT03813836

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +7 more
Locations
  • Aberdeen Royal Infirmary (NHS Grampian) Aberdeen, United Kingdom
  • Bristol Haematology and Oncology Centre (University Hospital Bristol NHS Foundation Trust) Bristol, United Kingdom
  • Western General Hospital (NHS Lothian) Edinburgh, United Kingdom
  • East Suffolk and North Essex NHS Foundation Trust Ipswich, United Kingdom
View Trial Details
Active, Not Recruiting

Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors

NCT05215574

Conditions
Adenocarcinoma, Adenoma, Adnexal Diseases, +83 more
Locations
  • NGM Clinical Study Site Gilbert, Arizona, United States
  • NGM Clinical Study Site Los Angeles, California, United States
  • NGM Clinical Study Site Sarasota, Florida, United States
  • NGM Clinical Study Site Tampa, Florida, United States
View Trial Details
Active, Not Recruiting

A RC198 Study in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors

NCT05867303

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +48 more
Locations
  • ICON Cancer Centre Wesley Auchenflower, Queensland, Australia
  • Southern Oncology Clinical Research Unit Bedford Park, South Australia, Australia
  • Cabrini Hospital Malvern Malvern, Victoria, Australia
  • Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
View Trial Details

Related conditions